Dr Angela Jennings
Medical Retina & Cataract Surgery
MBBS(Hons), BSc(Med), FRANZCO
A graduate of the University of New South Wales, Dr Jennings achieved academic distinction in being awarded the University Medal in Medicine. She was the recipient of numerous awards including the Medical Women’s Society of NSW Prize, the Wallace Worth Prize and the Combined Teaching Hospitals Senior Staff Prize. She undertook her Ophthalmology training at Sydney Eye Hospital and Westmead Hospitals from 2001 to 2004, before completing a Medical Retinal Fellowship with Professor Paul Mitchell at Westmead Hospital in Sydney.
Dr Jennings has was a treating investigator in two of the pivotal studies that introduced Lucentis and Eylea to clinical use - the Anchor trial and the VIEW-2 study. These medications are widely used to treat Age Related Macular Degeneration, Diabetic Eye Disease and Retinal Vein Occlusions. Dr Jennings continues to participate in clinical research as a Principal Investigator.
Dr Jennings has published articles in peer-reviewed scientific publications and regularly presents lectures on Macular Degeneration and other topics to Optometrists, General Practitioners and the general public. She was a Visiting Medical Officer at Westmead Hospital for a decade, where she greatly enjoyed helping to train a new generation of Ophthalmologists.
Dr Jennings is an experienced cataract surgeon and conducts a Medical Retina and General Ophthalmology clinic at our Castle Hill, Parramatta Dubbo, Mudgee and City locations. She is a member of The Australian and New Zealand Society of Retinal Specialists. Most of her spare time is spent keeping active with her three sons.